HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.

Abstract
Despite intensive chemotherapy and surgery treatment, lung and bone metastasis develop in about 30% of patients with osteosarcoma. Mechanisms for this preferential metastatic behavior are largely unknown. We investigated the role of the chemokine receptor 4 (CXCR4)/stromal cell-derived factor 1 (SDF-1) system to drive the homing of osteosarcoma cells. We analyzed the expression of the CXCR4 and SDF-1 proteins on several osteosarcoma cell lines and the effects of SDF-1 on migration, adhesion, and proliferation of these cancer cells. In vitro assays showed that the migration of osteosarcoma cells expressing CXCR4 receptor follows an SDF-1 gradient and that their adhesion to endothelial and bone marrow stromal cells is promoted by SDF-1 treatment. Moreover, the production of matrix metalloproteinase-9 is increased after SDF-1 exposure. We finally proved in a mouse model our hypothesis of the CXCR4/SDF-1 axis involvement in the metastatic process of osteosarcoma cells. Development of lung metastasis after injection of osteosarcoma cells was prevented by the administration of a CXCR4 inhibitor, the T134 peptide. These data show a possible explanation for the preferential osteosarcoma metastatic development into the lung, where SDF-1 concentration is high, and suggest that molecular strategies aimed at inhibiting the CXCR4/SDF-1 pathway, such as small-molecule inhibitors or anti-CXCR4 antibodies, might prevent the dissemination of osteosarcoma cells.
AuthorsEliana Perissinotto, Giuliana Cavalloni, Francesco Leone, Valentina Fonsato, Stefania Mitola, Giovanni Grignani, Nadia Surrenti, Dario Sangiolo, Federico Bussolino, Wanda Piacibello, Massimo Aglietta
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 11 Issue 2 Pt 1 Pg. 490-7 (Jan 15 2005) ISSN: 1078-0432 [Print] United States
PMID15701832 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CXCL12 protein, human
  • Chemokine CXCL12
  • Chemokines, CXC
  • Cxcl12 protein, mouse
  • Peptide Fragments
  • Receptors, CXCR4
  • Matrix Metalloproteinase 9
Topics
  • Animals
  • Bone Marrow Cells (metabolism, pathology)
  • Bone Neoplasms (metabolism, pathology)
  • Cell Adhesion
  • Cell Movement
  • Cell Proliferation
  • Chemokine CXCL12
  • Chemokines, CXC (metabolism)
  • Disease Progression
  • Endothelial Cells (metabolism, pathology)
  • Female
  • Humans
  • Lung Neoplasms (metabolism, prevention & control, secondary)
  • Matrix Metalloproteinase 9 (metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Osteosarcoma (metabolism, pathology)
  • Peptide Fragments (pharmacology)
  • Receptors, CXCR4 (antagonists & inhibitors, metabolism)
  • Signal Transduction
  • Stromal Cells (metabolism, pathology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: